Mankind Pharma on Wednesday said its consolidated net profit increased 55% to Rs 460 crore for the third quarter ended December 2023.
ADVERTISEMENT
The company had posted a net profit of Rs 296 crore in the October-December quarter of the last fiscal.
ADVERTISEMENT
Its revenue from operations rose to Rs 2,607 crore in the period under review from Rs 2,091 crore in the year-ago period, Mankind Pharma said in a statement.
Shares of the company ended 2.79% down at Rs 1,999.55 apiece on the BSE.
RECOMMENDED FOR YOU
CCI Approves Mankind Pharma's Acquisition Of Bharat Serums And Vaccines For Rs 13,630 Crore
Oct 01, 2024
Mankind Pharma Approves Raising Rs 10,000 Crore Via NCDs, CPs
Sep 30, 2024
Mankind Pharma Stock Soars As Investec Assigns 'Buy', Sees 38% Upside
Sep 20, 2024
Mankind Pharma Calls Board Meet On Sept. 20 To Mull Fundraise
Sep 17, 2024
POPULAR
1
Q2 Results: IREDA, TCS, Tata Elxsi, Avenue Supermarts To Report Earnings This Week—Full Schedule
2
Jaishankar Rules Out Bilateral Talks On Pakistan Visit, Focus On Multilateral Event
3
MEIL Commissions Five Solar Plants In Maharashtra
4
Oil ‘Tourists’ Pile Into Market Amid Biggest Rally in Two Years
5